An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia
Clinical trial NCT06447025 · RECRUITING
Trial details
- NCT number
- NCT06447025
- Sponsor
- Larimar Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-25
- Primary completion
- 2027-01-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.